Sponsor or institution
Clinical trials and research at Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. that are recruiting, at sites in 2 countries (most in China (1), Australia (1)). By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Efsubaglutide Alfa Injection in Obese Adolescents
This study tests whether Efsubaglutide Alfa can be safe and help with weight loss in adolescents aged 12 to 17 who are living with obesity.
-
Efsubaglutide alfa for adults with overweight or obesity (SPARKLE)
This trial will test whether efsubaglutide alfa injections given weekly or every few weeks help adults with overweight or obesity lose weight safely.
Quick answers
How many clinical trials run by Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.